Second-hand tobacco smoke and cardiovascular disease risk: An epidemiological review

Cardiology in Review

Volumn 21, Issue 2, 2013, Pages 94-100

  Dunbar, Andrew ^a   Gotsis, William ^b   Frishman, William ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

acute coronary syndrome; cardiovascular disease; coronary heart disease; environmental tobacco smoke; epidemiology; myocardial infarction; passive smoke exposure; review; second hand smoke; tobacco

Indexed keywords

CHOLESTEROL; CLOPIDOGREL; COTININE; OXIDIZED LOW DENSITY LIPOPROTEIN; TOBACCO SMOKE;

ACUTE CORONARY SYNDROME; ALCOHOL CONSUMPTION; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; EDUCATIONAL STATUS; ENDOTHELIAL PROGENITOR CELL; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; EUROPE; EXERCISE TOLERANCE; FRUIT; HEART INFARCTION SIZE; HEART RATE VARIABILITY; HOME ENVIRONMENT; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LAW; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MONOCYTE; OXIDATIVE STRESS; PASSIVE SMOKING; PHYSIOLOGICAL PROCESS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; TISSUE REPAIR; TOBACCO INDUSTRY; UNITED STATES; VASODILATATION; VEGETABLE; WORK ENVIRONMENT;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84873714457     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31827362e4     Document Type: Review

References (132)

1. Centers for Disease Control and Prevention. Women and smoking: a report of the Surgeon General (Executive Summary). MMWR 2002;51 (No. RR-12):1.
2. Pechacek TF, Asma S, Blair N, Eriksen M P. Tobacco: global and community solutions. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence-based Cardiology. 2nd ed. London: BMJ Books, 2003:103-13.
3. Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur J Cardiovasc Prev Rehabil. 2004;11:101-112. (Pubitemid 38591080)
4. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994;309:901-911.
5. Andrews JO, Tingen MS. The effect of smoking, smoking cessation, and passive smoke exposure on common laboratory values in clinical settings: a review of the evidence. Crit Care Nurs Clin North Am. 2006;18:63-9, xii. (Pubitemid 43402631)
6. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111:2684-2698. (Pubitemid 40740869)
7. Faught BE, Flouris AD, Cairney J. Epidemiological evidence associating secondhand smoke exposure with cardiovascular disease. Infamm Allergy Drug Targets. 2009;8:321-327.
8. Oberg M, Jaakkola MS, Woodward A, et al. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377:139-146.
9. Glantz SA, Tong EK. Tobacco industry efforts under mining evidence linking secondhand smoke with cardiovascular disease. Circulation. 2007;116:1845-1854 (Pubitemid 350287109)
10. National Research Council Committee on Passive Smoking. Environmental Tobacco Smoke: measuring exposures and assessing health effects. Washington, DC; National Academy Press; 1986.
11. Green CR, Rogman A. The tobacco chemist's research conference: a half-century forum for advances analytical methodology of tobacco and its products. Recent Adv Tobacco Sci. 1996; 22: 131.
12. Raucpach T, Schäfer K, Konstantinides S, et al. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J. 2006;27:386-392. (Pubitemid 43209161)
13. Flouris AD, Vardavas CI, Metsios GS, et al. Biological evidence for the acute health effects of secondhand smoke exposure. Am J Physiol Lung Cell Mol Physiol. 2010;298:L3-L12.
14. Frey PF, Ganz P, Hsue PY, et al. The exposure-dependent effects of aged secondhand smoke on endothelial function. J Am Coll Cardiol. 2012;59:1908-1913.
15. Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. Br Med J (Clin Res Ed). 1981;282:183-185. (Pubitemid 11188565)
16. Hirayama T. Lung Cancer in Japan: Effects of Nutrition and Passive Smoking. New York, NY: Verlag Chemie International; 1984.
17. Steenland K, Thun M, Lally C, et al. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation. 1996;94:622-628. (Pubitemid 26289214)
18. Humble C, Croft J, Gerber A, et al. Passive smoking and 20-year cardiovascular disease mortality among nonsmoking wives, Evans County, Georgia. Am J Public Health. 1990;80:599-601. (Pubitemid 20149902)
19. Hole DJ, Gillis CR, Chopra C, Hawthorne VM. Passive smoking and car-diorespiratory health in a general population in the west of Scotland. BMJ. 1989;299:423-427.
20. Garland C, Barrett-Connor E, Suarez L, et al. Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study. Am J Epidemiol. 1985;121:645-650. (Pubitemid 15056499)
21. Kawachi I, Colditz GA, Speizer FE, et al. A prospective study of passive smoking and coronary heart disease. Circulation. 1997;95:2374-2379. (Pubitemid 27224731)
22. Butler TL. The Relationship of Passive Smoking to Various Health Outcomes Among Seventh Day Adventists in California. Los Angeles, CA: University of California; 1988.
23. Sandler D P, Comstock G W, Helsing KJ, et al. Deaths from all causes in non-smokers who lived with smokers. Am J Public Health. 1989;79:163-167. (Pubitemid 19052360)
24. Svendsen KH, Kuller LH, Martin MJ, et al. Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1987;126:783-795. (Pubitemid 17161302)
25. McElduff P, Dobson AJ, Jackson R, et al. Coronary events and exposure to environmental tobacco smoke: a case-control study from Australia and New Zealand. Tob Control. 1998;7:41-46. (Pubitemid 128656148)
26. La Vecchia C, D'Avanzo B, Franzosi MG, et al. Passive smoking and the risk of acute myocardial infarction GISSI-EFRIM investigations. Lancet. 1993;341:505-506. (Pubitemid 23054574)
27. Lee PN, Chamberlain J, Alderson MR. Relationship of passive smoking to risk of lung cancer and other smoking-associated diseases. Br J Cancer. 1986;54:97-105. (Pubitemid 16093190)
28. Muscat JE, Wynder EL. Exposure to environmental tobacco smoke and the risk of heart attack. Int J Epidemiol. 1995;24:715-719.
29. Jackson RT. The Auckland Heart Study. Auckland, New Zealand: University of Auckland; 1989.
30. Dobson AJ, Alexander HM, Heller RF, et al. Passive smoking and the risk of heart attack or coronary death. Med J Aust. 1991;154:793-797.
31. He Y, Lam TH, Li LS, et al. Passive smoking at work as a risk factor for coronary heart disease in Chinese women who have never smoked. BMJ. 1994;308:380-384.
32. Tunstall-Pedoe H, Brown CA, Woodward M, et al. Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study. J Epidemiol Community Health. 1995;49:139-143.
33. Pitsavos C, Panagiotakos DB, Chrysohoou C, et al. Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob Control. 2002;11:220-225.
34. Rosenlund M, Berglind N, Gustavsson A, et al.; SHEEP Study Group. Environmental tobacco smoke and myocardial infarction among never-smokers in the Stockholm Heart Epidemiology Program (SHEEP). Epidemiology. 2001;12:558-564. (Pubitemid 32761998)
35. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997;315:973-980. (Pubitemid 27443124)
36. Matt GE, Bernert JT, Hovell MF. Measuring secondhand smoke exposure in children: an ecological measurement approach. J Pediatr Psychol. 2008;33:156-175. (Pubitemid 351197738)
37. He J, Vupputuri S, Allen K, et al. Passive smoking and the risk of coronary heart disease-a meta-analysis of epidemiologic studies. N Engl J Med. 1999;340:920-926. (Pubitemid 29141053)
38. Enstrom JE, Kabat GC. Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98. BMJ. 2003;326:1057.
39. Wagenknecht LE, Burke GL, Perkins LL, et al. Misclassifcation of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am J Public Health. 1992;82:33-36.
40. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998;279:1566-1570. (Pubitemid 28233013)
41. Thun M, Henley J, Apicella L. Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect. 1999;107 suppl 6:841-846. (Pubitemid 30068182)
42. Thun M, Howard G. Why is environmental tobacco smoke more strongly associated with coronary heart disease than expected? A review of potential biases and experimental data. Environ Health Perspect 1999; 107(suppl 6):853-858. (Pubitemid 30068184)
43. Wu AH. Exposure misclassifcation bias in studies of environmental tobacco smoke and lung cancer. Environ Health Perspect. 1999;107 suppl 6:873-877. (Pubitemid 30068187)
44. Steenland K, Sieber K, Etzel RA, et al. Exposure to environmental tobacco smoke and risk factors for heart disease among never smokers in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 1998;147:932-939. (Pubitemid 28244164)
45. Glantz SA, Parmley WW. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation. 1991;83:1-12.
46. Whincup PH, Gilg JA, Emberson JR, et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ. 2004;329:200-205.
47. Jarvis M, Tunstall-Pedoe H, Feyerabend C, et al. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health. 1984;38:335-339. (Pubitemid 15194784)
48. Seccareccia F, Zuccaro P, Pacifci R, et al.; Research Group of the MATISS Project. Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: the experience of the MATISS project. Eur J Epidemiol. 2003;18:487-492. (Pubitemid 36899552)
49. Nondahl DM, Cruickshanks KJ, Schubert CR. A questionnaire for assessing environmental tobacco smoke exposure. Environ Res. 2005;97:76-82. (Pubitemid 39336393)
50. de Leon J, Diaz FJ, Rogers T, et al. Total cotinine in plasma: a stable biomarker for exposure to tobacco smoke. J Clin Psychopharmacol. 2002;22:496-501.
51. Jarvis MJ, Primatesta P, Erens B, et al. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob Res. 2003;5:349-355. (Pubitemid 36764030)
52. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, et al. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77:1435-1438. (Pubitemid 18011591)
53. Gallo V, Neasham D, Airoldi L, et al. Second-hand smoke, cotinine levels, and risk of circulatory mortality in a large cohort study of never-smokers. Epidemiology. 2010;21:207-214.
54. Teo KK, Ounpuu S, Hawken S, et al.; INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTER-HEART study: a case-control study. Lancet. 2006;368:647-658. (Pubitemid 44223693)
55. Steptoe A, Wardle J. Passive smoking and risk of cognitive impairment in women who never smoke. Arch Intern Med 2012;172:271-272.
56. Bridevaux PO, Cornuz J, Gaspoz JM, et al.; SAPALDIA Team. Secondhand smoke and health-related quality of life in never smokers: results from the SAPALDIA cohort study 2. Arch Intern Med. 2007;167:2516-2523. (Pubitemid 350254913)
57. Weeks SG, Glantz SA, De Marco T, et al. Secondhand smoke exposure and quality of life in patients with heart failure. Arch Intern Med. 2011;171:1887-1893.
58. LeVois ME, Layard MW. Publication bias in the environmental tobacco smoke/coronary heart disease epidemiologic literature. Regul Toxicol Pharmacol. 1995;21:184-191.
59. Thun MJ. Passive smoking: tobacco industry publishes disinformation. BMJ. 2003;327:502-3; author reply 504.
60. Panagiotakos DB, Pitsavos C, Stefanadis C. Chronic exposure to second hand smoke and 30-day prognosis of patients hospitalised with acute coronary syndromes: the Greek study of acute coronary syndromes. Heart. 2007;93:309-312. (Pubitemid 46579518)
61. Pell J P, Haw S, Cobbe S, et al. Secondhand smoke exposure and survival following acute coronary syndrome: prospective cohort study of 1261 consecutive admissions among never-smokers. Heart. 2009;95:1415-1418.
62. Zhu BQ, Sun YP, Sievers RE, et al. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation. 1994;89:1282-1290. (Pubitemid 24076556)
63. Zornoff LA, Matsubara BB, Matsubara LS, et al. [Cigarette smoke exposure intensifes ventricular remodeling process following myocardial infarction]. Arq Bras Cardiol. 2006;86:276-282.
64. Duarte DR, Minicucci M F, Azevedo PS, et al. The role of oxidative stress and lipid peroxidation in ventricular remodeling induced by tobacco smoke exposure after myocardial infarction. Clinics (Sao Paulo). 2009;64:691-697.
65. Gu L, Pandey V, Geenen DL, et al. Cigarette smoke-induced left ventricular remodelling is associated with activation of mitogen-activated protein kinases. Eur J Heart Fail. 2008;10:1057-1064.
66. Helmers C. Short and long-term prognostic indices in acute myocardial infarction. A study of 606 patients initially treated in a coronary care unit. Acta Med Scand Suppl. 1973;555:7-26.
67. Aune E, Røislien J, Mathisen M, et al. The "smoker's paradox" in patients with acute coronary syndrome: a systematic review. BMC Med. 2011;9:97.
68. Brook RD, Franklin B, Cascio W, et al. Expert Panel on Population and Prevention Science of the American Heart Association. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004;109:2655-2671. (Pubitemid 38720571)
69. Pope CA 3rd, Eatough DJ, Gold DR, et al. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect. 2001;109:711-716. (Pubitemid 32791306)
70. Chen CY, Chow D, Chiamvimonvat N, et al. Short-term secondhand smoke exposure decreases heart rate variability and increases arrhythmia susceptibility in mice. Am J Physiol Heart Circ Physiol. 2008;295:H632-H639.
71. Dogan A, Yarlioglues M, Gul I, et al. Acute effects of passive smoking on left ventricular systolic and diastolic function in healthy volunteers. J Am Soc Echocardiogr. 2011;24:185-191.
72. Argacha JF, Adamopoulos D, Gujic M, et al. Acute effects of passive smoking on peripheral vascular function. Hypertension. 2008;51:1506-1511.
73. Khalfen ESh, Klochkov VA. [Effect of passive smoking on the physical tolerance of ischemic heart disease patients]. Ter Arkh. 1987;59:112-115.
74. Aronow WS. Effect of passive smoking on angina pectoris. N Engl J Med. 1978;299:21-24. (Pubitemid 8387367)
75. Leone A, Mori L, Bertanelli F, et al. Indoor passive smoking: its effect on cardiac performance. Int J Cardiol. 1991;33:247-251.
76. Pimm PE, Shephard RJ, Silverman F. Physiological effects of acute passive exposure to cigarette smoke. Arch Environ Health. 1978;33:201-213. (Pubitemid 9012728)
77. McMurray RG, Hicks LL, Thompson DL. The effects of passive inhalation of cigarette smoke on exercise performance. Eur J Appl Physiol Occup Physiol. 1985;54:196-200. (Pubitemid 15014004)
78. Kharitonov SA, Robbins RA, Yates D, et al. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med. 1995;152:609-612.
79. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothe-lial superoxide anion production. J Clin Invest. 1993;91:2546-2551. (Pubitemid 23182507)
80. Yates DH, Breen H, Thomas PS. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects. Am J Respir Crit Care Med. 2001;164:1043-1046. (Pubitemid 32971656)
81. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150-154. (Pubitemid 26017952)
82. Otsuka R, Watanabe H, Hirata K, et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA. 2001;286:436-441. (Pubitemid 32681486)
83. Kato M, Roberts-Thomson P, Phillips BG, et al. The effects of short-term passive smoke exposure on endothelium-dependent and independent vasodi-lation. J Hypertens. 1999;17:1395-1401. (Pubitemid 29509484)
84. Giannini D, Leone A, Di Bisceglie D, et al. The effects of acute passive smoke exposure on endothelium-dependent brachial artery dilation in healthy individuals. Angiology. 2007;58:211-217. (Pubitemid 46669110)
85. McCusker K, Hoidal J. Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smoke-exposed hamsters. Am Rev Respir Dis. 1990;141:678-682. (Pubitemid 20109158)
86. Sumida H, Watanabe H, Kugiyama K, et al. Does passive smoking impair endothelium-dependent coronary artery dilation in women? J Am Coll Cardiol. 1998;31:811-815. (Pubitemid 28186416)
87. Metsios GS, Flouris AD, Jamurtas AZ, et al. A brief exposure to moderate passive smoke increases metabolism and thyroid hormone secretion. J Clin Endocrinol Metab. 2007;92:208-211. (Pubitemid 46067532)
88. Bard RL, Dvonch JT, Kaciroti N, et al. Is acute high-dose secondhand smoke exposure always harmful to microvascular function in healthy adults? Prev Cardiol. 2010;13:175-179.
89. Davis JW, Shelton L, Watanabe IS, et al. Passive smoking affects endothe-lium and platelets. Arch Intern Med. 1989;149:386-389. (Pubitemid 19058524)
90. Rubenstein D, Jesty J, Bluestein D. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and fow conditions. Circulation. 2004;109:78-83. (Pubitemid 38056025)
91. Benowitz NL, Fitzgerald GA, Wilson M, et al. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol. 1993;22:1159-1167. (Pubitemid 23285770)
92. Imaizumi T, Satoh K, Yoshida H, et al. Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins. Atherosclerosis. 1991;87:47-55.
93. Sinzinger H, Kefalides A. Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet. 1982;2:392-393. (Pubitemid 12093068)
94. Schmid P, Karanikas G, Kritz H, et al. Passive smoking and platelet throm-boxane. Thromb Res. 1996;81:451-460.
95. Frishman WH: Pharmacotherapy of smoking cessation. In Frishman WH, Sica DA, eds. Cardiovascular Pharmacotherapeutics. 3rd ed. Minneapolis: Cardiotext Inc., 2011: 387-396.
96. Park KW, Kang SH, Kang J, et al. Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of 'smokers' paradox'. Heart. 2012;98:1000-1006.
97. Ueno M, Ferreiro JL, Desai B, et al. Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study. JACC Car-diovasc Interv. 2012;5:293-300.
98. Zeng DX, Xu YJ, Liu XS, et al. Cigarette smoke extract induced rat pulmonary artery smooth muscle cells proliferation via PKCα-mediated cyclin D1 expression. J Cell Biochem. 2011;112:2082-2088.
99. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al.; ATTICA study. Effect of exposure to secondhand smoke on markers of infammation: the ATTICA study. Am J Med. 2004;116:145-150. (Pubitemid 38121670)
100. Heitzer T, Ylä-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hyper-cholesterolemia. Role of oxidized LDL. Circulation. 1996;93:1346-1353.
101. Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation. 1998;97:2012-2016. (Pubitemid 28243662)
102. Matetzky S, Tani S, Kangavari S, et al. Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenic-ity. Circulation. 2000;102:602-604. (Pubitemid 30640657)
103. Noronha-Dutra AA, Epperlein MM, Woolf N. Effect of cigarette smoking on cultured human endothelial cells. Cardiovasc Res. 1993;27:774-778. (Pubitemid 23162671)
104. Shen Y, Rattan V, Sultana C, Kalra VK. Cigarette smoke condensateinduced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiol Heart Circ Physiol 1996;270: H1624-H1633.
105. Heiss C, Amabile N, Lee AC, et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Car-diol. 2008;51:1760-1771. (Pubitemid 351608499)
106. Weissberg PL, Rudd JH. Atherosclerotic biology and epidemiology of disease. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002, 3-14.
107. Pell J P, Haw S, Cobbe S, et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359:482-491.
108. National Smoking Cessation Monitoring Database. Edinburgh: NHS National Services Scotland, 2007. (Accessed August 7, 2011, at http://www. isdscotland.org/isd/4647.html.)
109. Sargent R P, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ. 2004;328:977-980. (Pubitemid 38530365)
110. Bartecchi C, Alsever RN, Nevin-Woods C, et al. Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation. 2006;114:1490-1496. (Pubitemid 44527004)
111. Barone-Adesi F, Vizzini L, Merletti F, et al. Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J. 2006;27:2468-2472. (Pubitemid 44522154)
112. Khuder SA, Milz S, Jordan T, et al. The impact of a smoking ban on hospital admissions for coronary heart disease. Prev Med. 2007;45:3-8. (Pubitemid 47001473)
113. Juster HR, Loomis BR, Hinman TM, et al. Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am J Public Health. 2007;97:2035-2039. (Pubitemid 351194735)
114. Cesaroni G, Forastiere F, Agabiti N, et al. Effect of the Italian smoking ban on population rates of acute coronary events. Circulation. 2008;117:1183-1188. (Pubitemid 351544066)
115. Lemstra M, Neudorf C, Opondo J. Implications of a public smoking ban. Can J Public Health. 2008;99:62-65.
116. Seo DC, Torabi MR. Reduced admissions for acute myocardial infarction associated with a public smoking ban: matched controlled study. J Drug Educ. 2007;37:217-226. (Pubitemid 47535798)
117. Vasselli S, Papini P, Gaelone D, et al. Reduction incidence of myocardial infarction associated with a national legislative ban on smoking. Minerva Cardioangiol. 2008;56:197-203. (Pubitemid 351702376)
118. Barnett R, Pearce J, Moon G, et al. Assessing the effects of the introduction of the New Zealand Smokefree Environment Act 2003 on acute myocardial infarction hospital admissions in Christchurch, New Zealand. Aust N Z J Public Health. 2009;33:515-520.
119. Sims M, Maxwell R, Bauld L, et al. Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ. 2010;340:c2161.
120. Herman PM, Walsh ME. Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona's comprehensive statewide smoking ban. Am J Public Health. Published online doi:10.2105/AJPH. 2009.179572.
121. Naiman A, Glazier RH, Moineddin R. Association of anti-smoking legislation with rates of hospital admission for cardiovascular and respiratory conditions. CMAJ. 2010;182:761-767.
122. Shetty KD, DeLeire T, White C, et al. NBER Working Paper 14790: Changes in Hospitalization and Mortality Rates Following Smoking Bans. Cambridge, CA: National Bureau of Economic Research, 2009. http://www.nber. org/papers/w14790. (accessed 18 Oct 2011).
123. Massachusetts Department of Public Health. Massachusetts sees fewer heart attack deaths since implementation of smoke-free workplace law (press release and powerpoint presentation). Boston, MA: 2008 November 12, 2008
124. Schane RE, Glantz SA. Education on the dangers of passive smoking: a cessation strategy past due. Circulation. 2008;118:1521-1523.
125. Glantz S, Gonzalez M. Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Lancet. 2012;379:1269-1271.
126. Meyers DG, Neuberger JS, He J. Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. J Am Coll Cardiol. 2009;54:1249-1255.
127. Richiardi L, Vizzini L, Merletti F, et al. Cardiovascular benefts of smoking regulations: the effect of decreased exposure to passive smoking. Prev Med. 2009;48:167-172.
128. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 2009;120:1373-1379.
129. Mackay DF, Irfan MO, Haw S, et al. Meta-analysis of the effect of comprehensive smoke-free legislation on acute coronary events. Heart. 2010;96:1525-1530.
130. Bruintjes G, Bartelson BB, Hurst P, et al. Reduction in acute myocardial infarction hospitalization after implementation of a smoking ordinance. Am J Med. 2011;124:647-654.
131. Cayla G, Sié P, Silvain J, et al. Short-term effects of the smoke-free legislation on haemostasis and systemic infammation due to second hand smoke exposure. The AERER study. Thromb Haemost. 2011;105:1024-1031.
132. Ong MK, Glantz SA. Cardiovascular health and economic effects of smoke-free workplaces. Am J Med. 2004;117:32-38. (Pubitemid 38798018)